Trial intelligence / Profile preview

Bioequivalence of 10 mg Ezetimibe Tablet vs Ezetrol in Healthy Thai Volunteers (Fasting)

TCTR20180927004Phase 1Not yet recruiting

Sponsor
Bio-innova
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by Bio-innova. Planned start Oct 2018; status: not yet recruiting.

02

Drugs

ezetimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on TCTR20180927004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180927004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call